Michael Hunkapiller is Director at PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). They have made 26 open-market trades across 2 companies since 2008, most recently 2021-02-26.
CIK 0001317102
9 open-market purchases totalling $3.9M since 2011, against 17 sales. Across 9 scored buys the stock is up 1.5% at ninety days, and 1.3 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -2.6% | +1.5% | +1.5% |
| Alpha | +3.2% | +1.3% | +1.3% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PACB | SELL | 2021-02-26 | 2021-03-02 | $31.02 | $14.5M | +1.2% | +1.0% | -21.1% |
| PACB | SELL | 2021-02-24 | 2021-02-26 | $34.30 | $41.6M | -1.0% | -11.7% | -16.5% |
| PACB | SELL | 2021-02-22 | 2021-02-24 | $36.53 | $41.7M | -23.3% | -13.9% | -28.0% |
| PACB | SELL | 2021-01-25 | 2021-01-27 | $36.34 | $9.1M | +23.1% | -2.6% | +7.1% |
| PACB | SELL | 2021-01-20 | 2021-01-22 | $37.53 | $46.8M | -5.8% | +1.3% | -17.5% |
| PACB | SELL | 2020-12-21 | 2020-12-23 | $24.36 | $34.1M | +0.6% | +33.1% | +16.1% |
| PACB | SELL | 2020-11-24 | 2020-11-25 | $14.39 | $21K | +53.9% | +86.9% | +153.7% |
| PACB | SELL | 2020-11-20 | 2020-11-24 | $15.06 | $12.0M | +51.3% | +90.9% | +163.5% |
| PACB | SELL | 2020-11-18 | 2020-11-20 | $15.71 | $1.2M | +24.2% | +51.0% | +180.1% |
| PACB | SELL | 2020-11-16 | 2020-11-18 | $15.90 | $1.4M | +17.7% | +31.8% | +204.1% |
| PACB | SELL | 2020-11-10 | 2020-11-13 | $14.79 | $28.8M | -14.4% | +23.1% | +201.2% |
| PACB | SELL | 2020-08-24 | 2020-08-26 | $6.54 | $6.4M | +0.0% | +42.1% | +121.4% |
| PACB | SELL | 2020-08-20 | 2020-08-24 | $6.51 | $5.8M | -4.4% | +28.0% | +124.8% |
| PACB | SELL | 2020-02-20 | 2020-02-24 | $4.50 | $1.5M | -4.1% | -19.1% | -6.8% |
| PACB | SELL | 2020-02-18 | 2020-02-20 | $4.49 | $5.4M | -21.8% | -36.6% | -18.4% |
| PACB | SELL | 2019-02-19 | 2019-02-20 | $7.19 | $192K | +1.4% | +0.6% | -3.9% |
| PACB | BUY | 2013-12-11 | 2013-12-12 | $4.13 | $413K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2013-11-21 | 2013-11-21 | $3.61 | $722K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-11-30 | 2012-12-04 | $1.76 | $271K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-11-27 | 2012-11-29 | $1.68 | $407K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-11-21 | 2012-11-26 | $1.44 | $269K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-11-19 | 2012-11-20 | $1.26 | $196K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-11-14 | 2012-11-16 | $1.15 | $303K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2012-08-06 | 2012-08-08 | $1.75 | $700K | -2.6% | +1.5% | +1.5% |
| PACB | BUY | 2011-08-09 | 2011-08-11 | $5.77 | $577K | -2.6% | +1.5% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.